v3.26.1
Note 2 - Summary of Significant Accounting Policies and Recently Issued Accounting Pronouncements (Details Textual)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
$ / shares
Mar. 31, 2025
Dec. 31, 2025
USD ($)
$ / shares
Jul. 31, 2024
USD ($)
Number of Operating Segments 2      
Accounts Receivable, Allowance for Credit Loss $ 0   $ 0  
Prepaid Expense, Noncurrent $ 752   $ 647 $ 1,200
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares $ 0.01   $ 0.01  
Customer Concentration Risk [Member] | Health Regen [Member] | Revenue Benchmark [Member]        
Concentration Risk, Percentage 100.00% 90.00%    
Clinical Activity Trials [Member]        
Prepaid Expense, Noncurrent $ 700      
Payments of Long-term Prepaid Contracts 200      
Other Deposits [Member]        
Prepaid Expense, Noncurrent $ 100